Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

Published 2010 View Full Article

Authors

Keywords

Journal

BLOOD

Volume 117, Issue 4, Pages 1141-1145

Publisher

American Society of Hematology

Online

2010-11-23

DOI

10.1182/blood-2010-03-277152

References

View 4 related references

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BLOOD

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Become a Peeref-certified reviewer

Ask a Question. Answer a Question.